Teza Capital Management LLC Enanta Pharmaceuticals Inc Transaction History

Teza Capital Management LLC

  • $904 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 11, 2020
SELL
$40.22 - $62.0 $204,076 - $314,588
-5,074 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$57.95 - $66.61 $294,038 - $337,979
5,074 New
5,074 $313,000
Q3 2018

Nov 14, 2018
SELL
$85.46 - $126.37 $243,988 - $360,786
-2,855 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$81.85 - $120.51 $233,681 - $344,056
2,855 New
2,855 $331,000

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $131M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email